#Libre – An example of ongoing variance within Diabetes care, looking at London area where this wasn’t supposed to happen…
A review of the variation across London in prescribing Libre.
A review of the variation across London in prescribing Libre.
Earlier today, the first NHS England CCG response to the Libre appeared on Twitter, from the East of England Priorities Advisory Committee. Looking to the […]
Two days ago, Abbott announced they had received FDA approval for the Freestyle Libre, some 3 years after European approval. That feels like a long […]
If you live in the Social Media bubble for T1D in the UK, you can’t fail to have noticed that there was a press release […]
Over the past couple of months, I’ve seen this question asked multiple times on many fora. Facebook, email lists and forums have all seen people […]
Earlier this week I published the first set of results of the survey of CGM and Libre users that I undertook last year. There was […]
Now that the survey to try and find out what CGM and Libre users thought of the technology and how it had affected their self-management, […]
2016. One hell of a year, and not always in the right way. But looking at it from my own personal transition on the Diabetes […]
A little over two years ago, the Abbott Freestyle Libre launched, to much fanfare and significant consumer trialling and direct patient marketing (anyone see a […]
As a long term user of the Libre and a recently started user of the Dexcom G4 with xBridge (note that I don’t own a […]
Copyright © 2026 | WordPress Theme by MH Themes